Product Information

AIRDUO RESPICLICK 113-14 MCG is a brand product labeled by Teva Respiratory, LLC, priced at $385.9814 per EA under NDC 59310081206. Its NADAC has been published 200 times since Aug 17, 2022.

The High Outlier badge above means this manufacturer's average price in the Fluticasone Propionate and Salmeterol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

AIRDUO RESPICLICK 113-14 MCG

Fluticasone Propionate and Salmeterol
$385.9814per EA
High Outlier

Strength

113; 14 ug/1; ug/1

NDC

59310081206

Classification

Brand

Dosage Form

POWDER, METERED

Route

RESPIRATORY (INHALATION)

Last Updated

6/18/2025

Approval Type

New Drug (NDA)

FDA Application

NDA208799

On Market Since

4/20/2017

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price Statistics

The NADAC for AIRDUO RESPICLICK 113-14 MCG has been published 200 times since Aug 17, 2022, and over the history we have for it it has risen 5.1%. The table below summarizes its recorded NADAC range and movement.

Current price$385.9814 per EA
All-time high$386.1858 (Dec 11, 2024)
All-time low$367.1967 (Aug 17, 2022)
52-week high$385.9814
52-week low$385.9814
Median price$385.2077
Average price$383.6063
Largest weekly change+4.9% (Jan 11, 2023)
Weeks tracked200
Tracking sinceAug 17, 2022

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+0.2%

5Y

N/A

All

+5.1%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 71%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of AIRDUO RESPICLICK 113-14 MCG?

The current National Average Drug Acquisition Cost (NADAC) for AIRDUO RESPICLICK 113-14 MCG, manufactured by Teva Respiratory, LLC, is $385.9814 per EA (NDC 59310081206), effective Jun 10, 2026.

How has the price of AIRDUO RESPICLICK 113-14 MCG changed over time?

Over the history we have for it, the NADAC for AIRDUO RESPICLICK 113-14 MCG has risen 5.1%. It has been tracked across 200 weekly CMS publications since Aug 17, 2022.

What are the highest and lowest recorded NADAC prices for AIRDUO RESPICLICK 113-14 MCG?

Since Aug 17, 2022, the NADAC for AIRDUO RESPICLICK 113-14 MCG has ranged from a low of $367.1967 (Aug 17, 2022) to a high of $386.1858 (Dec 11, 2024), with a median of $385.2077 per EA.

Are there cheaper alternatives to AIRDUO RESPICLICK 113-14 MCG?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, FLUTICASONE-SALMETEROL 113-14, is $113.8065 per EA — about 71% below AIRDUO RESPICLICK 113-14 MCG.

Who manufactures AIRDUO RESPICLICK 113-14 MCG?

AIRDUO RESPICLICK 113-14 MCG (NDC 59310081206) is labeled by Teva Respiratory, LLC, and CMS classifies it as a brand product.